
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Preclinical
Recipient : GeneFab
Deal Size : Undisclosed
Deal Type : Partnership
GeneFab & RegCell Partner for Treg Therapy Manufacturing in the U.S.
Details : The partnership will support the tech transfer and clinical manufacturing of RegCell’s Treg platform and accelerate U.S. clinical trials for autoimmune indications, including autoimmune hepatitis.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 07, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Preclinical
Recipient : GeneFab
Deal Size : Undisclosed
Deal Type : Partnership
